RESPONSIBLE PROVIDER IN ACCORDANCE WITH § 5 OF THE GERMAN TELEMEDIA ACT (TMG)
MorphoSys AG
Semmelweisstr. 7
82152 Planegg
Germany
Telephone: +49 89 899 27-0
Fax: +49 89 899 27-222
Email: info@morphosys.com
RESPONSIBLE IN ACCORDANCE WITH § 18 PARA 2 OF THE GERMAN INTERSTATE TREATY ON BROADCASTING [MEDIENSTAATSVERTRAG – MSTV]
Dr. Malte Peters (CR&DO)
MorphoSys AG
MANAGEMENT BOARD
Dr. Jean-Paul Kress (Chairman, CEO), Sung Lee (CFO), Dr. Malte Peters (CR&DO)
CHAIRMAN OF THE SUPERVISORY BOARD
Dr. Marc Cluzel
COMMERCIAL REGISTER
District Court of Munich, HRB 121023
VAT ID NO.
DE 155069821
REGULATORY AUTHORITY
Government of Upper Bavaria
REGISTERED TRADEMARKS
HuCAL®, HuCAL GOLD®, HuCAL PLATINUM®, CysDisplay®, RapMAT®, Ylanthia®, 100 billion high potentials®, Slonomics®, CyCAT®, and Monjuvi®/Minjuvi® are trademarks of the MorphoSys Group. Tremfya® is a trademark of Janssen Biotech, Inc. XmAb® is a trademark of Xencor, Inc.
DESIGN & PROGRAMMING
Digitas Pixelpark
www.digitaspixelpark.com
For better understandability, the use of male and female language forms is avoided. All personal descriptions apply equally to all genders.